What is she best known for?
The fields of study she is best known for:
- Cancer
- Immune system
- Gene
Her main research concerns Immunology, Stem cell, Suicide gene, Transplantation and Leukemia.
Her study in Immunology is interdisciplinary in nature, drawing from both Cell therapy and Graft-versus-host disease.
The study incorporates disciplines such as Myeloid, Transgene and Immunotherapy in addition to Stem cell.
Her Suicide gene study is associated with Genetic enhancement.
Specifically, her work in Transplantation is concerned with the study of Hematopoietic stem cell transplantation.
Her Leukemia study combines topics from a wide range of disciplines, such as Gene transfer, Zinc finger nuclease, Cancer immunotherapy, Endogeny and Tumor antigen.
Her most cited work include:
- HSV-TK Gene Transfer into Donor Lymphocytes for Control of Allogeneic Graft-Versus-Leukemia (1066 citations)
- Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cells (509 citations)
- Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells (454 citations)
What are the main themes of her work throughout her whole career to date?
Her primary scientific interests are in Immunology, Transplantation, Hematopoietic stem cell transplantation, Internal medicine and Leukemia.
Her Immunology research is multidisciplinary, incorporating perspectives in Graft-versus-host disease and Suicide gene.
Chiara Bonini interconnects Immunosuppression, Stem cell, Fludarabine and Intention-to-treat analysis in the investigation of issues within Transplantation.
Her research integrates issues of Cyclophosphamide, Human leukocyte antigen and Bone marrow in her study of Hematopoietic stem cell transplantation.
The Internal medicine study combines topics in areas such as Gastroenterology and Oncology.
Her study in Leukemia is interdisciplinary in nature, drawing from both Myeloid, CD34 and Myeloid leukemia.
She most often published in these fields:
- Immunology (62.16%)
- Transplantation (41.22%)
- Hematopoietic stem cell transplantation (38.18%)
What were the highlights of her more recent work (between 2016-2021)?
- Transplantation (41.22%)
- Hematopoietic stem cell transplantation (38.18%)
- Immunology (62.16%)
In recent papers she was focusing on the following fields of study:
Chiara Bonini mainly focuses on Transplantation, Hematopoietic stem cell transplantation, Immunology, Cell therapy and Cancer research.
Her Transplantation study combines topics in areas such as Myeloid, Haematopoiesis, Stem cell and Intensive care medicine.
Her Hematopoietic stem cell transplantation research includes elements of Post transplant, Leukemia, Hematologic Neoplasms and Graft-versus-host disease.
Chiara Bonini has researched Immunology in several fields, including Cell, Cyclophosphamide and Treosulfan.
The concepts of her Cell therapy study are interwoven with issues in Interleukin 6, Natural killer cell, Neurotoxicity and Oncology.
Her Cancer research study incorporates themes from T cell, Cancer, Immunotherapy and Antigen.
Between 2016 and 2021, her most popular works were:
- Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells (454 citations)
- Use of haploidentical stem cell transplantation continues to increase: the 2015 European Society for Blood and Marrow Transplant activity survey report (209 citations)
- T memory stem cells in health and disease (163 citations)
In her most recent research, the most cited papers focused on:
- Cancer
- Immune system
- Gene
Chiara Bonini mostly deals with Hematopoietic stem cell transplantation, Transplantation, Myeloid, Internal medicine and Disease.
Her Hematopoietic stem cell transplantation research incorporates themes from Immunology and Intensive care medicine.
Her Immunology research incorporates elements of Cell and Graft-versus-host disease.
Her study brings together the fields of Haematopoiesis and Transplantation.
Her studies deal with areas such as Leukemia and Myeloid leukemia as well as Myeloid.
Her study explores the link between Internal medicine and topics such as Oncology that cross with problems in Genetic enhancement, Chimeric antigen receptor, Young adult, Cell therapy and Cancer immunotherapy.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
